Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 20, Issue 12

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 20, Issue 12 (2011)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 20, Issue 12 (2011)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Volume 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

Identification of heptapeptides interacting with IFN-α-sensitive CML cells

Jia Liu, Han-chun Chen, Zhou-zhou Rao, Md. Asaduzzaman Khan, Xin-xing Wan, Ai-hua Xu, Nuo Zhang & Dian-zheng Zhang

Pages: 1583-1589

Published online: 18 Nov 2011

AbstractforIdentification of heptapeptides interacting with IFN-α-sensitive CML cells | Full Text | References | PDF (269.1 KB)

128 Views
2 CrossRef citations
0Altmetric

Reviews

Review Article

Adenosine receptor targeting in health and disease

Stefania Gessi, Stefania Merighi, Debora Fazzi, Angela Stefanelli, Katia Varani & Pier Andrea Borea

Pages: 1591-1609

Published online: 22 Oct 2011

AbstractforAdenosine receptor targeting in health and disease | Full Text | References | PDF (324.4 KB)

766 Views
68 CrossRef citations
0Altmetric

Review Article

The impact of multi-targeted cyclin-dependent kinase inhibition in breast cancer cells: clinical implications

Józefa Węsierska-Gądek & Matthias P Kramer

Pages: 1611-1628

Published online: 21 Oct 2011

AbstractforThe impact of multi-targeted cyclin-dependent kinase inhibition in breast cancer cells: clinical implications | Full Text | References | PDF (488.9 KB)

506 Views
15 CrossRef citations
0Altmetric

Review Article

Several down, a few to go: histamine H₃ receptor ligands making the final push towards the market?

Sebastiaan Kuhne, Maikel Wijtmans, Herman D Lim, Rob Leurs & Iwan JP de Esch

Pages: 1629-1648

Published online: 13 Oct 2011

AbstractforSeveral down, a few to go: histamine H₃ receptor ligands making the final push towards the market? | Full Text | References | PDF (553.3 KB)

753 Views
47 CrossRef citations
0Altmetric

Review Article

Investigational Notch and Hedgehog inhibitors – therapies for cardiovascular disease

Eileen M Redmond, Shaunta Guha, Dermot Walls & Paul A Cahill

Pages: 1649-1664

Published online: 18 Oct 2011

AbstractforInvestigational Notch and Hedgehog inhibitors – therapies for cardiovascular disease | Full Text | References | PDF (449.6 KB)

375 Views
11 CrossRef citations
0Altmetric

Review Article

Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications

Sadhna Sharma & Amandeep Singh

Pages: 1665-1676

Published online: 21 Oct 2011

AbstractforPhenothiazines as anti-tubercular agents: mechanistic insights and clinical implications | Full Text | References | PDF (366 KB)

377 Views
22 CrossRef citations
0Altmetric

Review Article

The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials

Andreas Varkaris, Paul G Corn, Sanchaika Gaur, Farshid Dayyani, Christopher J Logothetis & Gary E Gallick

Pages: 1677-1684

Published online: 28 Oct 2011

AbstractforThe role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials | Full Text | References | PDF (243.9 KB)

737 Views
55 CrossRef citations
0Altmetric

Review Article

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside

Bruno Vincenzi, Andrea Napolitano, Loretta D'Onofrio, Anna Maria Frezza, Marianna Silletta, Olga Venditti, Daniele Santini & Giuseppe Tonini

Pages: 1685-1705

Published online: 20 Oct 2011

AbstractforTargeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside | Full Text | References | PDF (435.6 KB)

277 Views
3 CrossRef citations
0Altmetric

Drug Evaluations

Article

Elacytarabine – lipid vector technology overcoming drug resistance in acute myeloid leukemia

Aine Carol Burke & Frank James Giles

Pages: 1707-1715

Published online: 01 Nov 2011

AbstractforElacytarabine – lipid vector technology overcoming drug resistance in acute myeloid leukemia | Full Text | References | PDF (283.4 KB)

328 Views
10 CrossRef citations
0Altmetric

Article

Potential use of exenatide for the treatment of obesity

Franco Folli MD PhD & Rodolfo Guardado Mendoza MD PhD

Pages: 1717-1722

Published online: 24 Oct 2011

AbstractforPotential use of exenatide for the treatment of obesity | Full Text | References | PDF (181.6 KB)

367 Views
11 CrossRef citations
0Altmetric

Article

Belinostat: clinical applications in solid tumors and lymphoma

L Rhoda Molife BMedSci BM BS MRCP MSc MD & Johann S de Bono BM BS FRCP MSc PhD

Pages: 1723-1732

Published online: 03 Nov 2011

AbstractforBelinostat: clinical applications in solid tumors and lymphoma | Full Text | References | PDF (291 KB)

417 Views
32 CrossRef citations
0Altmetric

Article

Nebivolol for the treatment of heart failure

Nicoletta Riva MD & Gregory YH Lip MD

Pages: 1733-1746

Published online: 08 Oct 2011

AbstractforNebivolol for the treatment of heart failure | Full Text | References | PDF (272.6 KB)

486 Views
7 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.20, Iss.12, 2011)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?